(Q36114391)

12 August 2017

0 references

1 reference

title

The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis (English)

1 reference

generalized anxiety disorder

12 August 2017

1 reference

1 reference

1 reference

6

Flávio Kapczinski

1 reference

12 August 2017

Ricardo Schmitt

1

1 reference

12 August 2017

Fernando Kratz Gazalle

2

1 reference

12 August 2017

Maurício Silva de Lima

3

1 reference

12 August 2017

Angelo Cunha

4

1 reference

12 August 2017

Juliano Souza

5

1 reference

12 August 2017

publication date

1 March 2005

1 reference

Brazilian Journal of Psychiatry

12 August 2017

published in

1 reference

12 August 2017

volume

27

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

18-24

1 reference

Phenomenology and course of generalised anxiety disorder.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462005000100007

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462005000100007

Pharmacologic treatment of generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462005000100007

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462005000100007

Paroxetine efficacy in the treatment of generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462005000100007

Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462005000100007

Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462005000100007

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462005000100007

10.1590/S1516-44462005000100007

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference